Delivery Order SPE2DB20D3101-SPE2DB25FRKP5

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,103.96 Firm Fixed Price Delivery Order contract is for the supply of REPATHA 140 MG/ML SURECLICK medical products. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,769.28 firm fixed-price delivery order is for the medication REPATHA 140 MG/ML SURECLICK ML. The contract has an ultimate completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,717.66 delivery order contract is for the supply of REPATHA 140 MG/ML SURECLICK, a medication. This contract is not set aside and is a firm fixed-price agreement. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,489.89 Firm Fixed Price Delivery Order is for the supply of REPATHA 140 MG/ML SURECLICK medication. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,064.82 firm fixed-price delivery order is for REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,402.64 firm fixed price delivery order is for the product "REPATHA 140 MG/ML SURECLICKML" and has a completion date of February 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,104.84, is a Firm Fixed Price Delivery Order for the supply of the medication REPATHA 140 MG/ML SURECLICK. The contract has an ultimate completion date of January 31, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,253.18 firm fixed-price delivery order is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The award has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,485.60 firm fixed-price delivery order contract is for the provision of REPATHA 140 MG/ML SURECLICKML, a cardiovascular medication. The contract has an ultimate completion date of May 17, 2023 and was awarded on May 16, 2023. This order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.70 firm fixed-price delivery order is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRKP5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,082.84 firm fixed-price delivery order is for the provision of REPATHA 140 MG/ML SURECLICK medication. The contract has an ultimate completion date of May 20, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This prime contract provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

The contract award is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and no subcontractors are mentioned. The contract supports the DLA's role in providing medical and pharmaceutical products to the U.S. military and other government agencies.

Generated 8/18/25, 9:44 AM